RXST RXSIGHT INC

RxSight, Inc. to Present at the Wells Fargo Healthcare Conference

RxSight, Inc. to Present at the Wells Fargo Healthcare Conference

ALISO VIEJO, Calif., Aug. 23, 2023 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Wells Fargo Healthcare Conference.

RxSight’s management is scheduled to participate in a fireside chat on Wednesday, September 6, 2023, at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation at: .

About RxSight, Inc.

RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery enabling doctors to customize and deliver high-quality of vision to patients after cataract surgery. Additional information about RxSight can be found at .

Company Contact:

Shelley Thunen

RxSight, Inc.

Investor Relations Contact:



EN
23/08/2023

Underlying

RXSTRXSIGHT INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on RXSIGHT INC

 PRESS RELEASE
Free
RXST RXSIGHT INC

RxSight, Inc. Reports Second Quarter 2025 Financial Results

RxSight, Inc. Reports Second Quarter 2025 Financial Results ALISO VIEJO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for the three months ended June 30, 2025. Key Company Highlights Reported second quarter 2025 revenue of $33.6 million, representing a decrease of 4% compared to the second quarter of 2024, reflecting: The sale of 27,380 Light Adjustable Lenses (LAL®/LAL+®), representing a 13...

August 7, 2025 1 EN
 PRESS RELEASE
Free
RXST RXSIGHT INC

RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors

RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors ALISO VIEJO, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced the appointment of Raymond W. Cohen to its Board of Directors. “We are thrilled to welcome Raymond W. Cohen to the RxSight Board of Directors,” said J. Andy Corley, Chairman of the Board at RxSight. “Ray’s extensive track record in leading and scaling medical technology companies will be inval...

August 4, 2025 1 EN
 PRESS RELEASE
Free
RXST RXSIGHT INC

RxSight, Inc. to Report Second Quarter 2025 Financial Results on Augus...

RxSight, Inc. to Report Second Quarter 2025 Financial Results on August 7, 2025 ALISO VIEJO, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, will report financial results for the second quarter of 2025 after the market close on Thursday, August 7, 2025. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. To participate in the conference call, please...

July 24, 2025 1 EN
 PRESS RELEASE
Free
RXST RXSIGHT INC

RxSight, Inc. Announces Preliminary Second Quarter 2025 Revenue and Re...

RxSight, Inc. Announces Preliminary Second Quarter 2025 Revenue and Revised 2025 Guidance ALISO VIEJO, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced select preliminary financial results for the second quarter 2025 and revised full-year 2025 guidance. The Company will host a conference call on Tuesday, July 8, 2025, at 5:00 p.m. Eastern Time. Preliminary Second Quarter 2025 Results Preliminary second quarter 2025 re...

July 8, 2025 1 EN
 PRESS RELEASE
Free
RXST RXSIGHT INC

RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology ...

RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum ALISO VIEJO, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Stifel Virtual Ophthalmology Forum. RxSight’s management is scheduled to participate in a fireside chat on Tuesday, May 27, 2025, at 10:30 a.m. Pacific Time / 1:30 p.m. Eastern Time. A live and archived webcast of the presentation will be availa...

May 20, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch